ConductScience.org, home

Trial · NCT01293838

Cipralex® for Anxiety Disorders in Adolescents

NCT01293838, Phase 1, Unknown, University of Ottawa

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Cipralex® for Anxiety Disorders in Adolescents. Trials, record NCT01293838. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01293838

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Cipralex® for Anxiety Disorders in Adolescents
NCT number
NCT01293838
Status
Unknown
Phases
Phase 1
Enrollment
30 participants, estimated
Lead sponsor
University of Ottawa
Conditions
Anxiety Disorder
Interventions
Cipralex®
First posted
2011-02-11
Last updated
2011-02-11

Source ClinicalTrials.gov

Registered outcomes3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryTreatment EfficacyAt week 16
Measures used to assess treatment efficacy: * The Anxiety Disorders Interview Schedule for DSM-IV, Research and Lifetime Version for Children and Parents (Silverman \& Albano, 1996) * Multidimensional Anxiety Scale for Children (March et al., 1997) * Youth Quality of Life Scale (Topolski et al., 2001), * Pediatric Anxiety Rating Scale (RUPP, 2002) * Beck Depression Inventory-2 (Beck et al., 1996 * Behavioral and Emotional Rating Scale-2 (Epstein \& Sharma, 2004), * Clinical Global Impression Scale-Severity and Improvement (Guy, W. \& ECDEU, 1976)
SecondaryPhysiological response to stressAt week 18 - see below
* Trier Social Stress Task for Children (TSST-C)\[Baseline and week 18\] * Salivary cortisol\[For baseline, samples will be collected in the home upon awakening/8 am, +30, +60 min, at 4 pm, and at 8 pm on 2 consecutive weekdays. Cortisol will also be measured from samples collected before and after the TSST-C(-1, +10, +20, +30, +45, and +60 min)\] * Salivary alpha-amylase\[Before (-1), and +1, +10, +20, and +30 min after the TSST-C\] * Heart rate variability\[Baseline and during the TSST-C\] * Acoustic Startle Response\[Baseline and in a "fear-potentiated" condition with an ASR system\] * Urine drug test
SecondarySuicide riskEach treatment visit (baseline then weeks 2, 4, 6, 8, 12, 16, 28)At each treatment visit, the clinician will elicit AEs and SAEs, and complete the Columbia-Suicide Severity Rating Scale (C-SSRS) (Posner et al, 2007)

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers17

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
2228929BACKGROUNDPubMed
2312652BACKGROUNDPubMed
8282656BACKGROUNDPubMed
8436689BACKGROUNDPubMed
8768346BACKGROUNDPubMed
8956679BACKGROUNDPubMed
9100431BACKGROUNDPubMed
9107149BACKGROUNDPubMed
9435761BACKGROUNDPubMed
11383961BACKGROUNDPubMed

1 to 10 of 17

See all 17 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01293838

GET https://conductscience.org/api/trials/v1/NCT01293838/registered